Key words: rapid tRNA decay/nuclear surveillance/S. cerevisiae/SUP4oc/tS(CGA)/intron/splicing 2 ABSTRACT During tRNA maturation in yeast, aberrant pre-tRNAs are targeted for 3'-5' degradation by the nuclear surveillance pathway, and mature tRNAs are targeted for 5'-3' degradation by the rapid tRNA decay (RTD) pathway, due to lack of certain body modifications or to destabilizing mutations. Here we show that the RTD pathway also targets pre-tRNAs through an unknown, but distinct, mechanism that occurs after nuclear export. Anticodon stem RTD variants of both tRNA Tyr and tRNA Ser(CGA) are substrates for pre-tRNA RTD, triggered by the accumulation of end-matured unspliced pre-tRNA due to altered secondary structure of the region comprising the anticodon stem-loop and the intron.
INTRODUCTION
In all organisms, the central role of tRNAs in decoding mRNA during translation places restrictions on the properties of tRNA. tRNAs must adopt a conserved structure to uniformly participate in translation (1) (2) (3) ; they must be selective in charging by their cognate synthetase (4) (5) (6) , and in their anticodon-codon interactions (7) (8) (9) (10) (11) ; they must be flexible enough for accommodation and passage through the ribosome (12) (13) (14) (15) (16) ; and they must be stable enough to have long half-lives, enabling participation in multiple rounds of translation (17) (18) (19) (20) . tRNAs undergo a highly complex maturation process. In the yeast Saccharomyces cerevisiae and other eukaryotes, tRNAs are transcribed by Pol III as pre-tRNAs with a 5' leader, a 3' trailer, and in some cases an intron, all of which must be removed before the tRNA can participate in translation (21). In vertebrates and higher eukaryotes, these end trimming and splicing steps are completed in the nucleus (22,23), but in S. cerevisiae and Schizosaccharomyces pombe, intron-containing pre-tRNAs are exported from the nucleus after end trimming and then spliced in the cytoplasm on the surface of the mitochondria by the heterotetrameric splicing endonuclease (SEN) complex (24-26). In addition, an extensive set of modifications are added to the body and anticodon loop throughout the course of processing (22,27,28), including a final set of modifications that occur after splicing, after retrograde import of spliced tRNAs into the nucleus, or after re-export of the tRNAs into the cytoplasm (29-32).
The necessity for proper tRNA maturation and function is evident from the numerous human diseases associated with incorrectly processed tRNAs. Hypomodification of tRNAs, caused by mutation of either the modifying enzyme or the tRNA itself, can result in numerous mitochondrial and neurological diseases (33-40); defects in tRNA splicing caused by mutations in the human SEN complex can cause pontocerebellar hypoplasia and neurodegeneration (41,42); and mutations in the aminoacyl tRNA synthetases can cause a host of neurological diseases (43, 44) .
In S. cerevisiae, the fidelity of tRNA maturation is monitored both as pre-tRNA, by the nuclear surveillance pathway, and as mature tRNA, by the rapid tRNA decay (RTD) pathway. The nuclear surveillance pathway acts through the TRAMP complex and the nuclear exosome to degrade pre-tRNAi Met lacking the m 1 A modification (18, (45) (46) (47) , and may also degrade as much as half of the total transcribed pre-tRNA, presumably due to random mutations or folding defects (17) . After maturation, tRNAs are subject to another round of surveillance by the rapid tRNA decay (RTD) pathway, which degrades certain hypomodified tRNAs and tRNAs with destabilizing mutations in the acceptor/T-stem, employing the 5'-3' exonucleases Rat1 in the nucleus and Xrn1 in the cytoplasm (19, 20, (48) (49) (50) . The RTD pathway targets tRNAs due to exposure of the 5' end arising from reduced stability of the acceptor/T-stem, as shown by both structure probing and Xrn1 assay of hypomodified tRNA Ser(CGA) (tS(CGA)) and tS(CGA) variants, and by Xrn1 assay of hypomodified tV(AAC) (48). The degradation of all identified substrates of the RTD pathway is suppressed by a met22Δ mutation, likely due to elevated levels of the metabolite 3', 5' adenosine bisphosphate (pAp) found in a met22∆ strain, which inhibits both Xrn1 and Rat1 in vitro and in vivo (20, 51, 52) . There is also evidence that the RTD pathway may be conserved in humans, since Xrn1 and the human Rat1 homolog Xrn2 can mediate the degradation of tRNAi Met after heat shock (53) .
Although the RTD pathway targets substrates due to 5' end exposure (48), it was surprising to find, from high throughput analysis of variants of the suppressor SUP4oc (tRNA Tyr(GUA) with a UUA anticodon), that the RTD pathway could also target variants with destabilizing mutations in the anticodon stem. Such anticodon stem mutations were not expected to significantly destabilize the 5' end and trigger RTD (54, 55) .
Here we show that RTD of anticodon stem variants is quantitatively equivalent to RTD of acceptor stem variants in vivo, despite the much larger exposure of acceptor stem variants to 5'-3' exonucleases in vitro. We explain this discrepancy by showing that anticodon stem RTD substrates have a defect in pre-tRNA maturation, causing accumulation of unspliced pre-tRNA that is degraded by the RTD pathway through an unknown mechanism, as it is not inhibited by deletion of XRN1 or mutation of RAT1. We provide evidence that mutations that restore pre-tRNA structure reduce pre-tRNA accumulation and pre-tRNA RTD. Furthermore, we find that pre-tRNA RTD and anticodon stem RTD is general since it also occurs in both tY(GUA) and tS(CGA) variants. We explain these results in terms of a model of opportunistic decay in which destabilizing variants are subject to surveillance at each step of tRNA biogenesis and after maturation, and are degraded due to a combination of instability and availability of each tRNA intermediate.
MATERIALS AND METHODS

Yeast strains
The yeast strains used are shown in Supplementary Table 1 . Deletions were introduced by standard PCR amplification of the appropriate strain from the YKO collection (56) (or of a derivative strain with a different drug marker), followed by linear transformation, and PCR of transformants to confirmation the deletion. The rat1-107 allele was introduced with a URA3 marker as described previously (20).
Construction and integration of variants of SUP4oc, tS(CGA), tV(AAC/CGA)
SUP4oc variants were constructed by annealing of overlapping oligomers (IDT) followed by ligation into the Bgl II Xho I site of the tRNA gene cassette of plasmid AB230-1, as previously described (54) . tS(CGA) variants and tV(AAC/CGA) were constructed in a similar manner. tRNA variants were integrated at the ADE2 site of strains by linear transformation of a Stu I fragment containing the tRNA cassette, the adjacent HIS3 marker, and flanking ADE2 sequences, deleting part of ADE2 (48). Three biological isolates of each strain were isolated and used for all of the experiments reported, unless otherwise noted.
Growth of cells for isolation of bulk RNA
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Three independent isolates of strains with integrated tRNA variants were grown overnight at 28°C in 5 mL YPD media (1% yeast extract, 2% peptone, 2% dextrose, supplemented with 80 mg/l adenine hemisulfate), inoculated into 5 ml fresh media at OD600 ~ 0.1, and grown to an OD ~1, and then 2 OD samples were harvested by microfugation, washed with 1 mL water, frozen on dry ice, and stored at -80°C. Then bulk RNA was extracted using hot phenol as described previously (57) , followed by addition of 20 µg glycogen, phenol-chloroform-isoamyl alcohol (PCA) extraction, two ethanol precipitations, and resuspension in ddH2O.
Purification of Xrn1 and the Rat1/Rai1 complex
Xrn1 was purified from yeast strain BCY123 (58), after galactose-induced expression of a PGAL1-XRN1 construct in which XRN1 was fused at its 3' terminus to the PT tag, bearing a protease 3C site-HA epitope-His6-ZZ domain of protein A, as described previously (48). Rat1/Rai1 was purified analogously from a dual PGAL1,10 expression plasmid expressing RAT1-PT and His10-RAI1 (59).
Purification of tRNAs
SUP4oc variants were purified together with tRNA Tyr using 1.0 mg bulk RNA from the corresponding met22Δ strain and the biotinylated oligomer MP 129 (nt 76-53), as previously described (48, 60) .
In vitro digestion with exonucleases
Purified tRNAs were analyzed for exonuclease sensitivity essentially as previously described (48). A purified mixture of tRNA Tyr and SUP4oc (7.5 ng) was melted at 95 °C for 10 minutes in buffer containing 25 mM Tris pH 8.0 and 150 mM NaCl, immediately placed on ice, refolded at 37°C for 20 minutes in buffer containing 13.9 mM Tris pH 8.0, 83.3 mM NaCl, 2.2 mM MgCl2, 0.55 mM DTT, 0.11 mg/mL BSA, and then incubated as indicated with purified Xrn1 or Rat1/Rai1 in buffer containing 4.5 mM Tris pH 8.0, 90 mM NaCl, 2.1 mM MgCl2, 0.6 mM DTT, 0.1 mg/mL BSA, 5% glycerol. Reactions were stopped on dry ice, extracted with PCA, ethanol precipitated with 20 µg of glycogen, and then resuspended in ddH2O.
Poison primer extension analysis of SUP4oc variants
To analyze relative amounts of SUP4oc and tRNA Tyr in bulk RNA or purified mixtures, we used a poison primer extension assay with an appropriate primer (Supplementary Table 2 ) and ddCTP or ddTTP, essentially as previously described (54) . Briefly, ~0.5 pmol of 5' radiolabeled primer and ~1.0 µg of bulk RNA was denatured by heating at 95 °C and then annealed in water, followed by primer extension with 2U AMV reverse transcriptase (Promega) in supplied buffer containing 1 mM ddNTP, and 1 mM remaining dNTPs, incubation for 1 hour at 50°C, and transfer to -20°C. Aliquots of reactions were diluted 2-fold in formamide dye, heated at 95°C for 3 minutes, and resolved on a 15% polyacrylamide gel (29:1) containing 7 M urea in 1 X TBE. The gel was dried on a Model 583 Biorad gel dryer at 78°C for 40 minutes, exposed and analyzed using an Amersham Typhoon phosphoimager and Image Quant v5.2.
The relative amount of SUP4oc variant in each sample is expressed as % tY(GUA) (% tY), calculated as the quotient of the signal for the SUP4oc variant (typically the G30 stop) divided by the endogenous tRNA Tyr signal (typically the G34 stop), each first corrected for background. The % tY was averaged over three biologically independent strains grown and analyzed in parallel, and the error calculated as a standard deviation. The RTD ratios were calculated as the quotient of the average % tY value in a met22Δ strain divided by the corresponding average % tY value in a MET22 + strain (analyzed in the same gel from primer extensions done at the same time), with the error propagated appropriately for a division operation.
We note that despite some variability in % tY from experiment to experiment, the RTD ratios obtained from MET22 + and met22∆ strains grown in triplicate and analyzed at the same time are largely consistent between experiments. The variability in % tY likely arises from variations in the hybridization efficiencies of the primer extension probe to SUP4oc variants in different sets of assays.
This results in variable % tY measurements for the same bulk RNA preparations assayed at different times, but the same % tY from biological triplicates assayed at the same time.
Northern analysis of SUP4oc Variants
For northern analysis, independently made strains were grown in parallel, bulk RNA was isolated, and for each sample, 1 µg RNA was mixed with an equal volume formamide dye, heated at 60°C for 5 minutes, and resolved on a 10% polyacrylamide (19:1), 7M urea 1X TBE gel, which was transferred onto a Amersham Hybond TM -N + membrane (GE Healthcare), crosslinked on a UV Stratalinker 2400, and hybridized to probes (~ 12 pmol 5' 32 P-labeled DNA oligomer) as indicated.
Oligomers are described in Supplementary Table 3 .
Acidic Northern analysis of SUP4oc Variants
To analyze aminoacylated tRNAs, RNA was prepared from cells with glass beads under acidic conditions at pH 4.5, and Northern analysis was done as described previously (19) . RNA was resolved on a 6.5% polyacrylamide (19:1), 8 M urea, 0.1 M sodium acetate (pH 5.0) gel and separated at 4°C for approximately 12 hours at 600 volts. The gel was transferred in 0.1M sodium acetate buffer onto an Amersham Hybond TM -N + membrane followed by crosslinking and hybridization as described above.
RESULTS
Anticodon stem variants are susceptible to RTD in vivo but not to RTD exonucleases in vitro
Because of our finding that numerous anticodon stem variants could provoke RTD in the absence of known mechanisms for them to significantly destabilize the tRNA 5' end (54), we quantitatively compared RTD of anticodon stem and acceptor stem SUP4oc variant substrates. We examined the tRNA levels of biological triplicates of three acceptor stem RTD variants, seven anticodon stem variants, and one anticodon loop variant ( Figure 1A ,B, and C). We used poison primer extension to directly compare tRNA levels of SUP4oc variants as a percentage of endogenous tY(GUA) in a MET22 + strain and in a met22Δ strain, in which the 5'-3' exonucleases of the RTD pathway are inhibited, and then calculated the ratio of these two values (met22Δ/MET22 + ) to obtain the RTD ratio (54, 61) . Consistent with previous findings, we found that a met22∆ mutation resulted in a large quantitative increase in the tRNA levels for all 11 tested variants and thus a substantial RTD ratio ( Figure 1C and D). Seven variants had an RTD ratio greater than 4 (C5U, A29U, G30A, C40U, U41A, U42A, G69C), and four had an RTD ratio between 2 and 4 (U2C, A28U, A31U, C32A), indicating that they were all RTD substrates. Moreover, the average RTD ratio of anticodon stem variants (5.4, or 5.0 counting the C32A anticodon loop variant) was similar to, or slightly greater than, that of the acceptor stem variants (4.4) . This finding emphasizes the unusual nature of anticodon stem RTD substrates in that despite their predicted inability to substantially increase exposure of the 5' end to exonucleases, they provoke RTD in vivo at least as effectively as mutations in the acceptor stem. The C32A variant is particularly notable as an RTD substrate since the C32 residue is in the anticodon loop immediately adjacent to the anticodon stem and, if anything, is predicted to slightly improve stability of the anticodon stem-loop (62) .
To directly determine if the similar in vivo RTD sensitivity of anticodon stem variants and acceptor stem variants was due to similar 5' end accessibility, we measured 5'-3' exonuclease activity in vitro on SUP4oc RTD variants, as we had previously done with tS(CGA) variants and Xrn1 (48). To assay decay, we used a biotinylated oligomer to purify SUP4oc variants together with endogenous tY(GUA), incubated the tRNAs with purified preparations of Xrn1 or Rat1/Rai1 complex (63, 64) , and assayed decay by poison primer extension, using the endogenous purified tY(GUA) as a control.
With Xrn1, we found that the U2C acceptor stem variant was highly susceptible to decay at 37°C, whereas the A29U and A31U anticodon stem variants were nearly as resistant as the negative control SUP4oc (Figure 2A and B). This assay was done at 37°C, as many RTD substrates are more sensitive to decay in vivo at high temperature (20, 55) . At 30°C, which is expected to be more stringent for tRNA decay, we still observed substantial sensitivity of the U2C variant to Xrn1, whereas the anticodon stem variants were both highly resistant ( Supplementary Figure 1 ).
With Rat1/Rai1 at 37°C, we observed very similar results to those with Xrn1. The SUP4oc acceptor stem U2C and C5U variants were highly susceptible to decay over a range of Rat1/Rai1 concentrations, whereas the A31U anticodon stem variant was highly resistant, and the A29U and C40U anticodon stem variants were moderately resistant ( Figure 2C and D).
The finding that anticodon stem variants were consistently more resistant to 5'-3' exonucleases in vitro than acceptor stem variants is consistent with our expectation that destabilization of the anticodon stem would have a limited effect on 5' end exposure, but is seemingly contradictory with our in vivo data showing that anticodon stem and acceptor stem variants were similarly sensitive to RTD. The discrepancy between our in vitro and in vivo data implied that the degradation of anticodon stem variants by the RTD pathway might have an additional aspect in vivo that we were not able to account for in vitro.
Anticodon stem variants accumulate pre-tRNA that is subject to RTD
We considered that the decay of anticodon stem variants measured in vivo might actually be the sum of the RTD pathway acting on both mature tRNA and pre-tRNA, although the RTD pathway had not previously been known to act on pre-tRNA. Since it was previously shown that an anticodon stem variant of another tRNA species had impaired tRNA maturation (65) , it seemed reasonable that SUP4oc anticodon stem variants might accumulate pre-tRNA that could be targeted by the RTD pathway.
To determine if the pre-tRNAs of anticodon stem variants were also RTD substrates, we used poison primer extension to look for increased pre-tRNA in a met22Δ strain relative to a MET22 + strain, which would be diagnostic of pre-tRNA RTD. The primer for this experiment extended from nt 51 in the 3' tRNA exon through the intron until residue intron-1 (In-1), and in principle would detect any of the unspliced precursors in the tRNA maturation pathway ( Figure 3A ).
We found evidence for substantial pre-tRNA RTD in our set of anticodon stem RTD variants.
Initial experiments showed that both the SUP4oc A29U and U41A anticodon stem variants accumulated a large amount of pre-tRNA in a MET22 + strain relative to the accumulation of SUP4oc (7.1-fold and 4.5-fold respectively), and the pre-tRNA levels were further increased in a met22Δ strain relative to SUP4oc (16.2-fold and 8.6-fold), resulting in pre-tRNA RTD ratios of 2.3 and 1.9 respectively ( Figure   3B ,C, and D). By contrast, although the SUP4oc C5U acceptor stem variant accumulated a modest amount of pre-tRNA relative to SUP4oc (2.4-fold), there was no further increase in a met22Δ strain, resulting in a pre-tRNA RTD ratio of 1.1. These results extended to our entire set of anticodon stem RTD variants. Each of the five other anticodon stem RTD variants examined also showed significant accumulation of pre-tRNA relative to SUP4oc in MET22 + strains (2.1 fold or more), which in each case was further increased in a met22∆ strain, resulting in pre-tRNA RTD ratios ranging from 1.6 to 5.9
( Figure 3C and D). By contrast, the acceptor stem variants U2C and G69C showed no substantial accumulation of pre-tRNA and no significant pre-tRNA RTD ratio. Thus, it is a general property that SUP4oc anticodon stem RTD substrates have substantial increases in pre-tRNA levels in both MET22 + and met22Δ strains, and have substantial pre-tRNA RTD ratios.
This finding offers a simple explanation for the discrepancy between the similar RTD ratios of anticodon stem and acceptor stem variants in vivo, and the relative resistance of anticodon stem variants to 5'-3' exonucleases in vitro. For anticodon stem variants, their susceptibility to pre-tRNA RTD would be captured by the poison primer extension measurements of mature SUP4oc tRNAs used to obtain RTD ratios (now referred to as overall RTD ratios), since overall RTD measured in this way is the sum of RTD of mature tRNA and of pre-tRNA. However, the reduced in vitro 5'-3' exonuclease susceptibility of anticodon stem variants relative to acceptor stem variants would remain as a discriminating difference between the two classes of RTD variants.
It is not clear which nuclease is inhibited by the met22Δ mutation and is responsible for pre-tRNA RTD. Pre-tRNA RTD of SUP4oc A29U and U41A variants was not significantly inhibited by either a rat1-107 mutation or an xrn1∆ mutation ( Figure 4A , B, and C), each of which was previously found to significantly inhibit overall RTD in specific tRNA species (20, 48) . Similarly, we did not observe inhibition of pre-tRNA RTD with trf4∆ or rrp6∆ mutations ( Figure 4D ), each known to inhibit 3'-5' pre-tRNA decay by the nuclear surveillance pathway (18,47), but not anticipated to be sensitive to the pAp buildup in a met22Δ mutant.
Destabilization of anticodon-intron base pairing causes pre-tRNA accumulation and decay
The large accumulation of unspliced pre-tRNA associated with pre-tRNA RTD of SUP4oc anticodon stem variants suggested that perturbation of the pre-tRNA structure might in some way inhibit maturation to trigger the decay. In intron-containing pre-tRNAs, the anticodon forms part of a central helix with residues in the intron, surrounded by two bulges that comprise a bulge-helix-bulge region, which is recognized and cleaved by the splicing endonuclease in the first step of splicing (66) (67) (68) (69) (70) . This characteristic pre-tRNA structure of the anticodon stem-loop and intron is predicted to be somewhat unstable in pre-tY(GUA) (62) , which has only four base pairs in the central helix between the anticodon region and the intron ( Figure 5A) ; moreover, the G34U ochre mutation of SUP4oc is predicted to destabilize the anticodon-intron pairing by disrupting the normal G34 pairing with intron residue In-11 ( Fig. 5A ), and to alter the pre-tRNA structure in the region. Thus, it seemed plausible that the U34 ochre mutation could be contributing to the accumulation of SUP4oc pre-tRNAs observed in some of the anticodon stem RTD variants.
We tested the importance of the G34U ochre mutation in pre-tRNA RTD of three SUP4oc variants (A29U, G30A, and A31U) by reconstructing derivatives with a native GUA anticodon (A29U GUA [ie, tY(GUA) A29U], G30A GUA , and A31U GUA ) and comparing their pre-tRNA levels and pre-tRNA RTD ratios by poison primer extension.
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The pre-tRNA RTD ratios were dramatically reduced in the A29U GUA and A31U GUA anticodon stem variants compared to the corresponding SUP4oc variants, from 2.4 to 1.3 for the A29U variant, and from 2.0 to 1.1 for the A31U variant ( Figure 5B and C). Moreover, pre-tRNA accumulation was also dramatically reduced in these variants in the met22Δ strain, 3.3-fold in the A29U variant (from 146 to 44 % pre-tY) and 4.1 fold in the A31U variant. In contrast, the pre-tRNA RTD ratio was only slightly reduced for the G30A GUA variant compared to the SUP4oc G30A variant, from 3.3 to 2.8, and the pre-tRNA accumulation was only slightly reduced in the met22Δ strain (1.2-fold). The results with all three tY(GUA) variants are consistent with a model in which pre-tRNA RTD is driven by pre-tRNA accumulation, which is in turn due to perturbation of the pre-tRNA structure that is important for splicing. The persistence of the G30A mutation in causing pre-tRNA RTD with either a native GUA anticodon or an ochre anticodon is consistent with the greater predicted disruption in pre-tRNA structure caused by the G30A mutation, compared to either the A29U or A31U mutations (62) .
This analysis also revealed two other important properties of pre-tRNA RTD. First, pre-tRNA RTD comprised a major component of the overall RTD of two of the variants, since the dramatic reduction in pre-tRNA RTD ratios for the A29U GUA and A31U GUA was matched by a similar reduction in their overall RTD ratios ( Figure 5D ). Second, substantial amounts of pre-tRNA RTD can occur in anticodon stem RTD variants with a natural GUA anticodon, since the G30A GUA variant had a large pre-tRNA RTD ratio of 2.8.
We further tested the importance of anticodon-intron pairing in pre-tRNA RTD by making a compensatory mutation of In-11 to restore the pairing of SUP4oc residue U34 (making a SUP4oc variant denoted as I-oc ), albeit with a U-A pair instead of the native G-C pair (Fig. 5A ). We found that the resulting SUP4oc A29U I-oc and SUP4oc A31U I-oc variants each had the anticipated reduction in pre-tRNA RTD ratio relative to the corresponding SUP4oc variants, but not as much of a reduction as in the corresponding tY GUA variants. Consistent with an intermediate effect on pre-tRNA RTD, we observed an intermediate reduction in overall RTD for the A29U I-oc and A31U I-oc variants relative to their SUP4oc and tY GUA counterparts ( Figure 5D ). The observed correspondence between restoration of anticodon-intron pairing and reduced pre-tRNA RTD emphasizes the importance of the structure of the pre-tRNA in the region of the anticodon stem-loop and intron for pre-tRNA RTD.
Anticodon stem mutations cause both RTD and pre-tRNA RTD in tS(CGA)
The finding of RTD associated with anticodon stem variants led us to speculate that anticodon stem RTD variants would be found in other intron-containing tRNAs, and that pre-tRNA RTD would likely be associated with them. We therefore attempted to design additional anticodon stem variants that would be subject to RTD in tS(CGA) ( Figure 6A ), a single copy essential tRNA gene that could be examined for function by a simple genetic test (48). We integrated a tS(CGA) anticodon stem variant into a tS(CGA)Δ [URA3 tS(CGA)] strain, so that cell growth dependent on the integrated variant could be tested after FOA selection to remove the URA3 + plasmid bearing the wild type tS(CGA) gene. We found that strains bearing each of three tested anticodon stem tS(CGA) variants (A29U, C40U, and C42U) behaved like RTD substrates, because they exhibited temperature sensitivity that could be suppressed by a met22Δ mutation ( Figure 6A and B), as was observed for the control tan1Δ trm44Δ mutant, previously shown to be due to RTD (20,71).
To assess tRNA decay of these variants, we first introduced a plasmid containing a tS(GCU/CGA) hybrid tRNA, bearing the body of tS(GCU) and a CGA anticodon, into the tS(CGA)Δ strain with an integrated tS(CGA) variant, thus allowing growth of strains at non-permissive temperatures and facile measurement of tS(CGA) variant levels by northern analysis. To probe specifically for tS(CGA) and not the nearly identical isoacceptor tS(UGA), we used a probe that hybridized to nt 17-37 of tS(CGA), which differs from tS(UGA) at residues 28 and 34, and used hybridization conditions yielding no signal in a WT strain that contained only tS(GCU/CGA) as a source of tS(CGA) ( Figure 6C the tS(CGA) C40U variant also had a substantial overall RTD ratio of 3.9 and a distinct pre-tRNA RTD ratio of 1.8, albeit accompanied by a modest p-value of 0.065 for pre-tRNA accumulation in the met22Δ background ( Supplementary Figure 2A and B) . By contrast, although the tS(CGA) A29U variant had substantial overall RTD, there was no obvious accumulation or degradation of pre-tRNA (Supplementary Figure 2C and D) . These results provide compelling evidence for overall RTD of anticodon stem variants of tS(CGA), accompanied in two cases by pre-tRNA RTD and accumulation of unspliced pre-tRNA. Thus, the pre-tRNA RTD decay pathway is a general phenomenon, and for the tS(CGA) C42U variant and the tS(CGA) C40U variant, pre-tRNA RTD occurred after end processing and before splicing.
Inhibition of splicing exacerbates pre-tRNA RTD of the SUP4oc A29U variant, whereas inhibition of nuclear export provokes nuclear surveillance
To precisely define the specific tRNA maturation defect of SUP4oc anticodon stem variants that leads to pre-tRNA RTD and the associated accumulation of unspliced pre-tRNA, we used mutants that perturbed specific steps of maturation. In yeast, intron-containing pre-tRNAs are end-processed in the nucleus (21), exported to the cytoplasm by either LOS1 or the MEX67/MTR2 heterodimer (72) , and then spliced on the surface of the mitochondria by the SEN complex (24,25). Since our analysis of the tS(CGA) C42U variant suggested that pre-tRNA RTD occurred after end processing, we focused on the nuclear export and splicing steps for analysis of pre-tRNA RTD of SUP4oc variants. If the pre-tRNA of SUP4oc anticodon stem variants was degraded at one of these steps, then slowing down that step would increase the availability of the pre-tRNA at that stage, resulting in increased pre-tRNA RTD.
To examine the importance of the nuclear export step in pre-tRNA RTD, we used the wellstudied los1Δ mutation, which causes nuclear accumulation of intron-containing pre-tRNA (73, 74) ; and to examine the splicing step, we used a temperature sensitive sen2-42 allele of the Sen2 catalytic subunit of the SEN complex, which accumulates unspliced pre-tRNA at 32°C (25). We generated los1Δ and sen2-42 mutants in both a MET22 + and met22Δ background, and then integrated the SUP4oc A29U anticodon stem variant to analyze pre-tRNA RTD by Northern analysis. As we had observed for the tS(CGA) C42U variant, analysis of the control LOS1 + and SEN2 + strains showed that pre-tRNA RTD of the SUP4oc A29U variant occurred at the level of end-matured unspliced pre-tRNA, rather than at the level of primary transcript or 5'-trimmed 3'-trailer containing unspliced pre-tRNA ( Fig.   7A, lanes b-g and o-t) , .
Our analysis of the sen2-42 strain showed that inhibition of splicing exacerbated pre-tRNA RTD of the SUP4oc A29U anticodon stem variant. As expected because of the inhibition of splicing in the sen2-42 mutant, there was a large increase in intron-containing pre-tRNA for each of three tested tRNAs (pre-tF(GAA), pre-tS(CGA), and pre-tW(CCA)), but none of these pre-tRNAs had significant pre-tRNA RTD ( Figure 7A, Supplementary Figure 3A ). By contrast, there was a significant increase in the pre-tRNA RTD ratio of the SUP4oc A29U anticodon stem variant in the sen2-42 mutant relative to that in the SEN2 + strain, from 5.4 to 10.9 ( Figure 7B and D) . This result provides strong evidence that the maturation defect of the SUP4oc A29U variant that causes pre-tRNA RTD lies at or before the splicing step.
As expected if pre-tRNA RTD occurs after export from the nucleus, inhibition of pre-tRNA nuclear export by the los1Δ mutation did not affect pre-tRNA RTD of the SUP4oc A29U variant. As anticipated for impaired pre-tRNA export, pre-tRNA levels for each of three controls (pre-tF(GAA), pre-tS(CGA) and pre-tW(CCA)) were significantly increased in both a los1Δ MET22 + and a los1Δ met22Δ strain, relative to the corresponding LOS1 + control strains ( Figure 7A , Supplementary Figure   3B ). By contrast, we found that the levels of SUP4oc A29U pre-tRNA were unexpectedly decreased in the los1Δ strain (compared to the LOS1 + control strain), and were decreased to similar extents in MET22 + and met22Δ strains, resulting in a very similar pre-tRNA RTD ratio in both a LOS1 + and a los1Δ background (Fig. 7A , compare lanes h-m to b-g, Figure 7C and D). Thus, the reduced pre-tRNA levels of the SUP4oc A29U variant in a los1Δ mutant appear to be due to another decay pathway, not regulated by MET22.
This additional pre-tRNA decay observed in a los1Δ mutant is due to the nuclear surveillance pathway, since the reduced pre-tRNA levels of the SUP4oc A29U variant in a los1Δ strain, relative to a LOS1 + strain, were restored upon mutation of a known component of the nuclear exosome, RRP6, ( Figure 8A and B) , which degrades substrate pre-tRNAs from the 3' end (75, 76) . The concomitant increase in mature SUP4oc A29U tRNA levels in the los1Δ rrp6Δ strain ( Figure 7A ) underscores that pre-tRNA decay by the nuclear surveillance pathway contributes significantly to overall production of mature tRNA for this variant in this background.
DISCUSSION
The results described here show that RTD of anticodon stem variants occurs in part through a previously undescribed pre-tRNA RTD pathway, which targets pre-tRNAs that accumulate due to altered structure of the anticodon stem-loop and intron, likely resulting in inefficient splicing. Pre-tRNA RTD can contribute substantially to overall RTD since mutations that suppress pre-tRNA RTD result in comparable suppression of overall RTD ( Figure 5 ), and pre-tRNA RTD is a general phenomenon, since it can occur in both tY(GUA) and tS(CGA) variants bearing native anticodons and thus participating in normal translation ( Figures 5 and 6 ). In all previously described cases, RTD has only been documented to act on mature tRNA (19,20,49), and decay of pre-tRNA has only been attributed to 3'-5' exonucleolytic decay by the nuclear surveillance pathway (17, 18, 47) .
The accumulation of pre-tRNA that drives pre-tRNA RTD appears to be directly related to the pre-tRNA anticodon stem-loop and intron structure, which is important for splicing in vivo. Anticodonintron pairing is highly conserved in archaeal and yeast intron-containing pre-tRNAs as part of the bulge-helix-bulge motif important for splicing (66, 67, 69, 70, (77) (78) (79) , and may also be important in metazoans (68) . The importance of the central helix is underscored by our results that disruption of the central helix tended to increase pre-tRNA RTD, whereas restoration of the helix tended to reduce pre-tRNA RTD ( Figure 5 ). The importance of the 3' bulge structure is underscored by prominent pre-tRNA RTD in variants predicted to have an intact central helix, but with mutations affecting the bulge, including the tY(GUA) G30A, tS(CGA) C40U, and tS(CGA) C42U variants ( Figures 5 and 6) .
Remarkably, the pre-tRNA RTD pathway is not inhibited by mutation of the known exonucleases of the RTD pathway, or of known components of the nuclear surveillance pathway ( Figure 4 ). We envision three possibilities for the mechanism. First, pre-tRNA RTD might actually be due to Rat1, if the rat1-107 allele is not strong enough to inhibit pre-tRNA RTD. Since RAT1 is essential, obtaining such a mutation might be difficult, and use of the rat1 ts allele (80,81) would not be possible for experiments at 28°C; furthermore, the effect of the rat1-107 mutation on Rat1 activity has not been measured at 28°C. Second, pre-tRNA RTD might be due in part to another 5'-3' exonuclease, such as Dxo1 or Rrp17 (82, 83) , which are expected to be inhibited by the pAp accumulation caused by a met22Δ mutation (51, 52, 84) . Third, it is conceivable that pre-tRNA RTD might involve decay by an endonuclease such as Rny1 (85) or the splicing endonuclease itself (86), due to the prolonged presence of unspliced pre-tRNA as a consequence of the altered structure of the pre-tRNA. The involvement of an endonuclease in pre-tRNA decay would be similar in this regard to nonsense-mediated decay of mRNA, which involves both an endonuclease and an exonuclease (87), and would require inhibition by pAp to explain the met22Δ-dependent effects. Full understanding of the mechanism of pre-tRNA decay will undoubtedly lead to new insights in RNA quality control mechanisms.
The results outlined here suggest a model of opportunistic decay in which tRNA is constantly under surveillance through each step of biogenesis and as mature tRNA, with decay occurring as a consequence of the availability and instability of each state of the tRNA, by either the RTD pathway or the nuclear surveillance pathway. The nuclear surveillance pathway targets initial pre-tRNA transcripts of pre-tRNAi Met lacking m 1 A58, and a large portion of WT tRNAs soon after transcription (17, 18, 47) .
Results described here show that end-matured unspliced pre-tRNA is subjected to two rounds of quality control: It is targeted for pre-tRNA RTD after nuclear export and before or at the splicing step, based on analysis of the effect on pre-tRNA RTD of mutations that inhibit each step ( Figure 7) ; and it can be targeted by the nuclear surveillance pathway, particularly if it is retained in the nucleus. In this model, the substantial overall RTD of anticodon stem SUP4oc variants is due to a combination of pre-tRNA RTD, triggered by their altered intron-exon structure and presumed inefficient splicing, coupled with the distinct, but relatively inefficient, 5'-3' decay of anticodon stem variants after splicing, resulting in similar overall RTD to that of acceptor stem variants. Subsequent to maturation, tRNAs with destabilizing mutations or lacking specific body modifications are targeted by the RTD pathway (19,20,49,54), particularly at elevated temperatures, which leads to increased instability and attack (48, 55) . RTD is in competition with cellular proteins that bind charged tRNA, including EF-1A (49, 88) and tRNA synthetases such as ValRS for RTD of tV(AAC) (88) . RTD may also be in competition with the trafficking machinery, since mature cytoplasmic tRNA lacking m 2,2 G is degraded by RTD or is subject to retrograde import into the nucleus (50). This model of opportunistic decay is similar to the previously proposed scavenger mechanism attributed to RNA quality control pathways that also monitor tRNAs in Escherichia coli (89) (90) (91) .
This model of opportunistic decay underscores the high degree of evolutionary tuning required for all tRNA species to avoid the multiple quality control decay pathways, in addition to their more well studied evolution to function efficiently and accurately in translation. Since availability and instability are twin drivers of the RTD pathway, and likely also of the nuclear surveillance pathway, each tRNA species must have evolved for optimized processing efficiency of each intermediate, in addition to stability, to prevent access by the nucleases of the decay pathways, as well as to ensure timely maturation of tRNA for increased translation efficiency. Since the components of RTD and nuclear surveillance are widely conserved in eukaryotes, it seems likely that the tRNA decay pathways will be conserved in metazoans (53) , and that the selection of tRNAs for processing efficiency and stability will also be conserved. This raises the possibility that some of the numerous isodecoders in metazoans (92, 93) will have different susceptibilities to decay in addition to differences in expression and function (93, 94) .
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